Associate Director
Pfizer
Dr. Elliot DeHaan is an Associate Director in Vaccines Clinical Research & Development at Pfizer, Inc. and an Infectious Disease physician by training. Dr. DeHaan was a Medical Monitor and Efficacy Lead for the Phase III RENOIR trial (2021-2023), and currently serves as the lead clinician for the MONET trial looking at the immunogenicity of Abrysvo(TM) in At-Risk and Immunocomrpomised persons. Prior to his role at Pfizer, he was a clinician with a focus on the clinical care of People Living with HIV at academic hospitals in New York City since 2010, most recently at New York Presbyterian-Weill Cornell (2017-2021). He also served on the New York State Department of Health AIDS Institute Medical Care Criteria Committee 2015-2021.